HR
AGN

Howe & Rusling’s Allergan plc AGN Stock Holding History

Howe & Rusling’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-337
Closed -$60K – 954
2020
Q1 		$60K Sell
337
-1,473
-81% -$277K 0.01% 239
2019
Q4 		$346K Sell
1,810
-555
-23% -$100K 0.06% 150
2019
Q3 		$398K Sell
2,365
-23
-1% -$3.75K 0.07% 146
2019
Q2 		$400K Sell
2,388
-23
-1% -$3.19K 0.07% 142
2019
Q1 		$353K Buy
2,411
+1,149
+91% +$167K 0.06% 147
2018
Q4 		$169K Buy
1,262
+297
+31% +$48.7K 0.04% 172
2018
Q3 		$184K Sell
965
-37
-4% -$6.8K 0.03% 164
2018
Q2 		$167K Sell
1,002
-63
-6% -$10.1K 0.03% 163
2018
Q1 		$179K Sell
1,065
-7,058
-87% -$1.18M 0.03% 176
2017
Q4 		$1.33M Sell
8,123
-8,111
-50% -$1.46M 0.24% 82
2017
Q3 		$3.33M Sell
16,234
-699
-4% -$163K 0.62% 64
2017
Q2 		$4.12M Sell
16,933
-574
-3% -$135K 0.84% 49
2017
Q1 		$4.18M Buy
17,507
+5,149
+42% +$1.2M 0.84% 45
2016
Q4 		$2.6M Sell
12,358
-6,458
-34% -$1.34M 0.57% 63
2016
Q3 		$4.33M Sell
18,816
-2,761
-13% -$675K 0.93% 51
2016
Q2 		$4.99M Sell
21,577
-1,191
-5% -$275K 1.1% 37
2016
Q1 		$6.1M Sell
22,768
-720
-3% -$206K 1.38% 20
2015
Q4 		$7.34M Sell
23,488
-1,870
-7% -$557K 1.68% 9
2015
Q3 		$6.89M Buy
25,358
+30
+0.1% +$9.21K 1.71% 11
2015
Q2 		$7.69M Sell
25,328
-382
-1% -$114K 1.68% 10
2015
Q1 		$7.65M Buy
25,710
+25,155
+4,532% +$7.17M 1.72% 13
2014
Q4 		$143K Hold
555
– – 0.03% 171
2014
Q3 		$134K Buy
+555
New +$124K 0.03% 176

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Howe & Rusling's AGN Position: Q2 2020 in Review

Howe & Rusling sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 337 shares — an estimated $60K sold.

Howe & Rusling first reported a position in AGN in Q3 2014 and held it in 23 quarters. The position peaked at $7.69M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Howe & Rusling reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Howe & Rusling sold 337 Allergan plc shares in Q2 2020, an estimated $60K.
  • Howe & Rusling first reported a position in Allergan plc in Q3 2014 and held it in 23 quarters.
  • Howe & Rusling's Allergan plc position peaked at $7.69M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Howe & Rusling's 13F filing for Q2 2020, filed 15 Jul 2020.